Support

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:18

Masahiko Kusumoto

Written by
Sunday, 08 August 2021 11:18

Hirokazu Watanabe

Written by
Sunday, 08 August 2021 11:18

Yukihiro Yoshida

Written by
EDUCATION
Master of Medicine, The University of Tokyo, Japan. 9/2016 - Graduated
Graduate School of Medicine, Faculty of Medicine.
Specialized in thoracic surgery.

Bachelor of Medicine, The University of Tokyo, Japan. 3/1998 - Graduated
School of Medicine, Faculty of Medicine.

WORK EXPERIENCE
Staff, Department of Thoracic Surgery, National Cancer Center Hospital 6/2017 - Present
Director of the Surgery Department, Asahi General Hospital 4/2013 - 5/2017
Chief Doctor for Surgery, Asahi General Hospital 4/2010 - 3/2013
Assistant Professor, Department of Immunotherapeutics (Medinet), The University of Tokyo Hospital 7/2008 - 3/2010
Doctor, Department of Thoracic Surgery, The University of Tokyo Hospital 4/2007 - 6/2008
Doctor, Department of Thoracic Surgery, National Cancer Center Hospital 4/2006 - 3/2007
Research Resident, Pathology Department, National Cancer Center Research Institute 4/2005 - 3/2006
Chief resident (Department of Thoracic Surgery), National Cancer Center Hospital 6/2003 - 3/2005
Resident (Department of Surgery), National Cancer Center Hospital 6/2000 - 5/2003
Junior Resident at Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan 5/1998 - 4/2000

QUALIFICATIONS
Board Certified Specialist of Japan Surgical Society
Board Certified General Clinical Oncologist of Japanese Board of Cancer Therapy
Specialist of Thoracic Surgery

AWARDS
JJCO Paper of the Year 2008 2008/10/29, The 67th Annual Meeting of the Japanese Cancer Association, Nagoya.
Young Investigator Award, The 17th Annual Meeting of Asian Society for Cardiovascular and Thoracic Surgery 2009/3/4-8, Taipei, Taiwan.
Young Investigator Travel Award The 2009 IASLC WCLC 2009/7/31-8/4, San Francisco, California, USA.
JSS Young Researcher Award. 2013

PATENTS
Method of processing medical images, device, system, and program (Patent No: 2015-226214).
Method, device, and program that classifies malignancy of cancer (Unexamined Patent Application: 2008-200366)

MEMBERSHIPS
Member of Japan Surgical Society.
Member of The Japan Lung Cancer Society
Member of Non Profit Organization The Japanese Association for Chest Surgery.
Member of Japanese Association for Thoracic Surgery.
Member of International association for the study of lung cancer (IASLC).
Member of Japan Society for Respiratory Endoscopy.
Member of Japan Society of Clinical Oncology.

SPECIALIZATION
Thoracic surgery.
Sunday, 08 August 2021 11:18

Kazuo Nakagawa

Written by
Sunday, 08 August 2021 11:18

Masaya Yotsukura

Written by
Sunday, 08 August 2021 11:18

Sara Pilotto

Written by
Dr. Pilotto is a medical oncologist, assistant professor at the University of Verona. She completed her graduate studies and residency in medical oncology with full marks and honors at the University Hospital Trust of Verona (Italy) and she trained in the Translational Research Unit at the Pangaea Biotech laboratory, Quiron-Dexeus University Hospital, Barcelona (Spain) thanks to a fellowship award of the International Association for Lung Cancer (IASLC) in 2015. In 2019, she completed her PhD in Inflammation, Immunity and Cancer at the University of Verona (Italy).
Dr. Pilotto is member of the Young investigators Lung Cancer Group of EORTC, of the Lung cancer Guidelines Experts Panel of Italian Association of Medical Oncology (AIOM) and member of the ESMO faculty for the Non-Metastatic NSCLC and other Thoracic Malignancies faculty group and of the ESMO Press & Media Affairs Committee. She was reviewer for the Projects and/or Research Grants for IASLC (2017-2019) and member of the ESMO leadership program 2019.
Main Research/Clinical Interest Areas: clinical and translational research in lung cancer; prognostic and predictive models; methodology of clinical trials; comprehensive approach to cancer patient (i.e. nutrition, physical activity).
Sunday, 08 August 2021 11:18

Brendon Stiles

Written by
Sunday, 08 August 2021 11:18

Silvia Novello

Written by
Silvia Novello, MD, PhD is Full Professor of Medical Oncology in the Oncology Department at San Luigi Hospital in Orbassano, Italy, part of the University of Turin. She earned her medical degree and completed the postgraduate training in Respiratory Medicine and Medical Oncology at the University of Turin and partially at the Institut Gustave Roussy, in France. Currently, she is head of the Thoracic Oncology Unit at the San Luigi Hospital, Orbassano (Turin), where she also tutors medical students and Postgraduate students in Respiratory Medicine and Medical Oncology and Deputy Director of the Oncology Dept.

Prof. Novello’s research interests include thoracic malignancies, primary prevention, gender differences in lung cancer, basic, translational and clinical applied research on lung cancer and mesothelioma, including pharmacogenomics. She is involved as PI in many International and national controlled clinical trials evaluating new approaches in diagnosis and lung cancer therapy.

From July 2012 until 2016, Prof Novello has been a Member of the Board of Directors of the International Association for the Study of Lung Cancer and since October 2016 Member of the Board of Directors of the Italian Association of Medical Oncology, past Secretary and now part of the EORTC Lung Cancer Group and member of several scientific societies including the American Society of Clinical Oncology, American Thoracic Society and the European Society of Medical Oncology.
Currently, she is the President of WALCE (Women Against Lung Cancer in Europe), a non profit European Association founded in 2006 in Turin, Italy, part of the scientific Committee of LuCe (Lung cancer Europe) and also member of the Scientific Committee of Bonnie J Addario Lung Cancer Foundation and Member of the Scientific Committee of ICAPEM (Investigación sobre Cáncer de Pulmón en Mujeres).

She is the author or co-author of over 150 publications in peer-reviewed journals.
Sunday, 08 August 2021 11:18

Giorgio Vittorio Scagliotti

Written by
Giorgio Scagliotti is a Full Professor of Medical Oncology. He was Chief of the Department of Oncology at the University of Turin until September 2017 and now he is member of the Administrative Board of the University of Turin, Italy, and Chief of the Medical Oncology Unit at the S. Luigi Hospital, Orbassano (Turin). He earned his medical degree and completed postgraduate training in Respiratory medicine, Internal medicine, and Medical oncology at the University of Turin. His research interests include basic and clinical research in lung cancer, including pharmacogenomics. He is affiliated to several scientific societies and he has authored and co - authored over 300 publications.
He is coordinator of national, European and international clinical trials on the diagnosis and treatment of lung cancer.
He was President IASLC (International Association for the Study of Lung Cancer) for the period 2017-2019 and he is now Interim CSO.
Sunday, 08 August 2021 11:18

Paolo Bironzo

Written by
Page 278 of 371